Pamidronate
Treatment of conditions associated with increased osteoclast activity:
- Tumour-induced hypercalcaemia
- Osteolytic lesions in patients with bone metastases associated with breast cancer
- Multiple myeloma stage III
Treatment of conditions associated with increased osteoclast activity:
- Tumour-induced hypercalcaemia
- Osteolytic lesions in patients with bone metastases associated with breast cancer
- Multiple myeloma stage III
Download the Pamidronate SPC. You will need Adobe Reader to view this document.